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Introduction
The endoplasmic reticulum (ER) is the major organelle
of synthesis of protein and forms a membranous net-
work throughout the cell. According to Shimizu and
Hendershot [1], about one third of the total proteins
produced are synthesized in the ER. The ER lumen pos-
sesses a unique environment for high quality control for
protein folding and assembly. It contains high concen-
trations of molecular chaperones, folding enzymes, and
ATP, which aid in proper maturation of proteins [2].
However, if the amount of proteins to be folded exceeds
the capacity of the folding machineries, unfolded pro-
teins will accumulate in the ER and Unfolded protein
response (UPR) will start. UPR aims at regaining the
homeostasis inside the ER by attenuating the protein
translation, activating the folding machineries, degrada-
tion of the unfolded proteins, and finally apoptosis. Acti-
vating transcription factor 4 (ATF4) is a central factor in
the UPR pathways which is involved in folding and pro-
cessing of secretory proteins. Our previous research
showed that ATF4 over-expression is efficient for
increasing the productivity of antithrombin-III [3,4]. In
this study, we investigated if this approach is product-
specific or not.
Materials and methods
Cell line and medium
Serum-free adapted Chinese hamster ovary DP-12-SF
(CHO DP-12-SF) cell line (producing human anti-IL-8
IgG1) and Dulbecco Modified MEM medium supple-
mented with 10% dialyzed fetal bovine serum (FBS) and
200nM methotrexate were used in this study.
Vector construction
The ATF4 expression plasmid was constructed using
CHO ATF4cDNA into KpnI/XbaIs i t eo ft h e
pcDNA3.1/Hygro(+) expression vector (Invitrogen,
C a r l s b a d ,C A ,U S A ) ,d e s i g n a t e da sp c D N A 3 . 1 / H y g r o
(+)-ATF4.
Transfection and selection
The pcDNA3.1/Hygro(+)-ATF4 vector was transfected
into CHO DP-12-SF cell line using a TransIT-LT1
transfection reagent (Mirus bio Madison, WI USA). Sin-
gle cell clones were obtained using the limiting dilution
method. The transfected cell lines were selected using
200μg/ml hygromycin.
Chromosomal integration of ATF4
Genomic DNA was isolated after 72 h of cultivation
using DNeasy blood and tissue extraction kit (Qiagen,
Chatsworth, CA, USA). The primers 5`-TAATAC-
GACTCACTATAGGG-3` and 5`-TAGAAGGCA-
CAGTCGAGG-3` were employed for the amplification
of non-coding region of pcDNA3.1/Hygro(+)-ATF4 for
detection of the integration of the designated plasmid
into the CHO chromosome. PCR was performed using
Ex Taq polymerase (Takara Bio, Otsu, Shiga JAPAN)
with 100 ng of the genomic DNA.
Confirmation of ATF4 expression
RNA was isolated after 72 h of cultivation using RNeasy
mini kit (Qiagen). cDNA equivalent to 1μgo ft h ep r e -
viously prepared RNA was prepared using omniscript
RT kit (Qiagen) and PCR was performed using the same
primers for chromosomal detection.
Cell and antibody concentrations
Cell concentration was determined using Coulter Vi-
Cell Automated Cell Viability Analyzer (Beckman
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tion was determined by sandwich enzyme linked immu-
nosorbent assay (ELISA) [5]. Kinetic parameters were
calculated as described previously [3].
Real time PCR: The quantification of mRNA of heavy
and light chains of IgG was performed by the SYBR
Green real-time RT-PCR meth o d( A p p l i e dB i o s y s t e m s ,
Foster City, CA, USA) using the StepOnePlus Real-Time
PCR System.
Results and discussion
The gene encoding ATF4 was cloned from CHO-K1
inserted into the multiple cloning site of pcDNA3.1 vec-
tor with hygromycin cassette as a selection marker. The
ATF4 expression vector was then transfected into CHO
DP-12-SF cell line [5], producing humanized anti IL-8
Immunoglobulin-1 (IgG1). Twenty six single cell clones
were then established using the limiting dilution
method. To examine if pcDNA3.1/Hygro(+)-ATF4 was
integrated into the CHO chromosome or not, PCR ana-
lysis were performed using the primers designed for
non-coding region of the expression vector. Only 5
clones were confirmed with the insert at 1.2 Kb; CHO
DP-12-ATF4-3, -9, -10, -12, and-16. Reverse Transcrip-
tase-Polymerase Chain Reaction analyses revealed that
only 3 clones, CHO DP-12-ATF4-10, -12, and -16,
showed positive ATF4 expression. After 144 hours of
cultivation, only clones with confirmed ATF4 expression
showed significant increase in specific IgG1 production
rate ranging from 1.8 to 2.5 times the parental CHO
DP-12-SF cell. Clone DP-12-ATF4-16 that showed the
h i g h e s ti n c r e a s ei ns p e c i f i cp r o d u c t i v i t yw i t ha b o u tn o
change in the specific growth rate was subjected to
further analysis for quantification of mRNA of heavy
and light chains to determine if over-expression affects
the transcription of mRNA or not. The result was found
in agreement with our previous research that over-
expression of ATF4 did not significantly change the
level of the product mRNA [4]. It suggested that ATF4
over-expression might improve the translation and the
secretion without affecting the transcription.
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